Results 141 to 150 of about 222,938 (359)
Immunologically measurable insulin (IMI) in normal, obese and obese, diabetic subjects after intravenous administration of glucose, tolbutamide and glucagon. [PDF]
F. Melani +3 more
openalex +1 more source
Abstract In the 2021 European Society of Cardiology (ESC) heart failure (HF) guidelines, sodium–glucose cotransporter 2 (SGLT2) inhibitors were recommended for the prevention of HF in patients with type 2 diabetes mellitus (T2DM) and for the treatment of HF with reduced ejection fraction (HFrEF).
Marco Metra +25 more
wiley +1 more source
The physiological effect of glucagon on fat-mobilisation [PDF]
Pierre Lefèbvre
openalex +1 more source
The value of uACR. CKD, chronic kidney disease; CVD, cardiovascular disease; eGFR, estimated glomerular filtration rate; uACR, urine albumin‐to‐creatinine ratio. Abstract The high disease burden and bidirectional relationship of chronic kidney disease (CKD), heart failure (HF) and other cardiovascular disease (CVD) necessitate the need for early ...
Biykem Bozkurt +2 more
wiley +1 more source
The Role of Glucose, Glucagon and Glucocorticoids in the Regulation of Liver Glycogen Synthesis [PDF]
Henri De Wulf, H G Hers
openalex +1 more source
The ADHF‐ED trial. ADHF, acutely decompensated heart failure; CHF, chronic heart failure; ED, emergency department; EF, ejection fraction; MRA, mineralocorticoid receptor antagonist; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide. Created with the support of AI (ChatGPT).
Michael Kunz +9 more
wiley +1 more source
Detection of Insulin in Insulin-Deficient Islets of Patients with Type 1 Diabetes
Type 1 diabetes (T1D) is related to the autoimmune destruction of β-cells, leading to their almost complete absence in patients with longstanding T1D.
Yuliya Krivova +4 more
doaj +1 more source

